K101683

Substantially Equivalent

INFINITI CYP2C19 ASSAY

Applicant: Autogenomics, Incorporated
Product code: NTI
Advisory panel: Clinical Toxicology
Date received: 2010-06-15
Decision date: 2010-10-25
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Vista, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.